# Laparoscopic Assisted Plane Block (LAPB) Trial

> **NCT03730402** · PHASE4 · TERMINATED · sponsor: **Santa Barbara Cottage Hospital** · enrollment: 34 (actual)

## Conditions studied

- Opioid Use

## Interventions

- **DRUG:** Bupivacaine
- **DRUG:** Exparel 266 milligram Per 20 ML Injection
- **DRUG:** Saline

## Key facts

- **NCT ID:** NCT03730402
- **Lead sponsor:** Santa Barbara Cottage Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-02-04
- **Primary completion:** 2021-04-14
- **Final completion:** 2021-04-14
- **Target enrollment:** 34 (ACTUAL)
- **Why stopped:** There were not enough attendings/residents working on the study throughout the COVID-19 pandemic in order to enroll the number of patients required to meet statistical significance.
- **Last updated:** 2021-07-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03730402

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03730402, "Laparoscopic Assisted Plane Block (LAPB) Trial". Retrieved via AI Analytics 2026-09-24 from https://api.ai-analytics.org/clinical/NCT03730402. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*